4.5 Article

A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibition

Related references

Note: Only part of the references are listed.
Article Food Science & Technology

Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans

Rafael De la Torre et al.

MOLECULAR NUTRITION & FOOD RESEARCH (2014)

Article Multidisciplinary Sciences

Identification of a Novel Function of CX-4945 as a Splicing Regulator

Hyeongki Kim et al.

PLOS ONE (2014)

Article Cell Biology

Riquiqui and Minibrain are regulators of the Hippo pathway downstream of Dachsous

Joffrey L. Degoutin et al.

NATURE CELL BIOLOGY (2013)

Article Chemistry, Medicinal

DYRK1A Kinase Inhibitors with Emphasis on Cancer

A. Ionescu et al.

MINI-REVIEWS IN MEDICINAL CHEMISTRY (2012)

Article Biochemistry & Molecular Biology

Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)

Tatyana Adayev et al.

ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2011)

Article Biochemistry & Molecular Biology

Specific CLK Inhibitors from a Novel Chemotype for Regulation of Alternative Splicing

Oleg Fedorov et al.

CHEMISTRY & BIOLOGY (2011)

Review Biochemistry & Molecular Biology

DYRK family of protein kinases: evolutionary relationships, biochemical properties, and functional roles

Sergi Aranda et al.

FASEB JOURNAL (2011)

Review Biochemistry & Molecular Biology

MNB/DYRK1A as a multiple regulator of neuronal development

Francisco J. Tejedor et al.

FEBS JOURNAL (2011)

Review Biochemistry & Molecular Biology

The role of DYRK1A in neurodegenerative diseases

Jerzy Wegiel et al.

FEBS JOURNAL (2011)

Article Biochemistry & Molecular Biology

Structural basis of CX-4945 binding to human protein kinase CK2

Andrew D. Ferguson et al.

FEBS LETTERS (2011)

Article Biochemistry & Molecular Biology

Dyrk1A-mediated phosphorylation of Presenilin 1: a functional link between Down syndrome and Alzheimer's disease

Young Shin Ryu et al.

JOURNAL OF NEUROCHEMISTRY (2010)

Article Multidisciplinary Sciences

Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A

Yasushi Ogawa et al.

NATURE COMMUNICATIONS (2010)

Article Chemistry, Medicinal

Evaluation of substituted 6-arylquinazolin-4-amines as potent and selective inhibitors of cdc2-like kinases (Clk)

Bryan T. Mott et al.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)

Review Biochemistry & Molecular Biology

Down syndrome-recent progress and future prospects

Frances K. Wiseman et al.

HUMAN MOLECULAR GENETICS (2009)

Article Biochemistry & Molecular Biology

DYRK1A-mediated hyperphosphorylation of Tau - A functional link between Down syndrome and Alzheimer disease

Soo-Ryoon Ryoo et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Biochemistry & Molecular Biology

Dyrk1A phosphorylates α-synuclein and enhances intracellular inclusion formation

Eun Joo Kim et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2006)

Article Neurosciences

DYRKIA BAC transgenic mice show altered synaptic plasticity with learning and memory defects

Kyoung-Jin Ahn et al.

NEUROBIOLOGY OF DISEASE (2006)

Article Multidisciplinary Sciences

NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21

Joseph R. Arron et al.

NATURE (2006)

Article Neurosciences

Alterations in the phenotype of neocortical pyramidal cells in the Dyrk1A+/- mouse

R Benavides-Piccione et al.

NEUROBIOLOGY OF DISEASE (2005)

Article Chemistry, Multidisciplinary

Detailed analysis of grid-based molecular docking: A case study of CDOCKER - A CHARMm-based MD docking algorithm

GS Wu et al.

JOURNAL OF COMPUTATIONAL CHEMISTRY (2003)

Article Biochemistry & Molecular Biology

Dyrk1A haploinsufficiency affects viability and causes developmental delay and abnormal brain morphology in mice

V Fotaki et al.

MOLECULAR AND CELLULAR BIOLOGY (2002)